Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares to the proposed US$4.20 per share acquisition offer from CB Biotechnology, an affiliate of Future Pak. In a July 3 report, Uddin said the total offer, comprised of US$3.01 in cash and up to US$1.19 […]
Medexus Pharmaceuticals is a buy, Research Capital saysResearch Capital analyst Andre Uddin maintained a “Buy” rating and C$5.55 price target on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSXV:MDP) in a June 26 note, following fourth-quarter fiscal 2025 results that showed stabilizing revenue and progress in reducing debt. Medexus reported Q4 revenue of $24.8-million, nearly matching Uddin’s estimate of […]